Treatment with sofosbuvir and ledipasvir without ribavirin for 12 weeks is highly effective for recurrent hepatitis C virus genotype 1b infection after living donor liver transplantation: a Japanese multicenter experience
Yoshihide Ueda(Kagawa Prefectural Central Hospital), Yoshihiko Maehara(Kyushu University), Nobuhisa Akamatsu, Susumu Eguchi(Nagasaki University), Akihiko Soyama, Tomoharu Yoshizumi(Kyushu University), Toru Ikegami(Jikei University School of Medicine), Ryoichi Goto(Hokkaido University), Shinji Üemoto(Shiga University of Medical Science), Hideaki Okajima(Kanazawa Medical University), Masahiro Shinoda(Keio University), Akinobu Taketomi(Hokkaido University), Yuko Kitagawa(Keio University), Norihiro Kokudo(National Center for Global Health and Medicine)
Cited by 30
Related Papers
Trans-ancestry mutational landscape of hepatocellular carcinoma genomes
|Nature Genetics|2014|780
Neither Multiple Tumors Nor Portal Hypertension Are Surgical Contraindications for Hepatocellular Carcinoma
|Gastroenterology|2008|765
Prognostic Impact of Anatomic Resection for Hepatocellular Carcinoma
|Annals of Surgery|2005|641